To our knowledge, this is the first description of an ARHGAP25‐related bone disorder, demonstrating a novel form of monogenic skeletal disorder resulting from abnormal GTPase activity and giving evidence for a critical role for RhoGAP signaling in bone metabolism and pathology. Here, ARHGAP25 is linked to bone disorder.